The Life Raft Group Attends 18th Annual CTOS Meeting in NYC
From October 30th to November 2nd the Life Raft Group staff members attended the annual Connective Tissue Oncology Society (CTOS) Meeting in NYC.
IRBs and the LRG Patient Registry
Institutional Review Boards (IRBs) are the core of the well-established U.S. system for the protection of human research participants.
Kie Go Turns Knowledge Into Action
In early 2012, I was having gastric discomfort, so I took over-the-counter medication and it seemed to feel better.
WE are the CURE – GIST is the Paradigm
Over the past seven years, thanks to the dedication and support of the GIST community, the LRG Research Team has challenged the traditional cancer research norms and set new standards for how research can [...]
Dr. Brian Rubin Says LRG Research Team will Cure GIST
Dr. Brian Rubin of the LRG Research Clinic in Cleveland talks about the research we are able to do because of our amazing research team. He goes on to state that it is only a matter of time before we cure GIST. Our only obstacle is funding.
Pregnancy Outcomes in Patients with CML Treated with Imatinib
Is pregnancy for me?, is a common question among GIST patients. At present there isn't a lot of data on pregnancy and GIST. The prescription information on Gleevec clearly warns of risks if a [...]
Proton-Pump Inhibitor Side Effects
Many GIST patients use a Proton-pump inhibitor (PPI) to combat the side effects of nausea and acid reflux. PPI's help treat gastroesophageal reflux disease, or GERD, when stomach acid backs up into the esophagus. Three [...]
FDA asks ARIAD to suspend marketing and sales of Iclusig (ponatinib)
The U.S. Food and Drug Administration (FDA) has asked ARIAD Pharmaceuticals, the manufacturer of Iclusig (ponatinib) to suspend marketing and sales of ponatinib because of the risk of life-threatening blood clots and severe narrowing of [...]
Stivarga Approved for Canadian GIST Patients
Health Canada has expanded approval for the use of Stivarga to fight Gastrointestinal Stromal Tumours (GIST), according to an article from CNW. Bayer announced that Stivarga will now be available for treatment of adult patients with [...]
AACR Releases 2013 Cancer Progress Report
The AACR has released it's 2013 Cancer Progress report. The report is a comprehensive educational tool that illustrates the return on investments in cancer research and biomedical science. It discusses the various ways medical teams continue [...]